Upcoming Financial Results Announcement
InspireMD, Inc. (NASDAQ: NSPR), renowned for its innovative CGuard Prime carotid stent system designed for the prevention of stroke, has exciting news to share. The company announced that it is preparing to unveil its financial results for the second quarter of 2025. The announcement is set to take place on an upcoming Tuesday, with a conference call and webcast scheduled for 8:30 a.m. Eastern Time, where the executive team will dive into the financial results as well as recent developments within the company.
Participation in the Earnings Call
For those interested in the financial outcomes, InspireMD encourages potential participants to dial in to the earnings call through two separate lines: one for domestic callers and another for international listeners. This is an excellent opportunity for shareholders and potential investors to gain insight into the company's performance and future direction. If you are unable to attend the live call, a recording will be made available shortly after the event, ensuring that all stakeholders have access to this crucial information.
Webcast Access
The live webcast can be accessed directly through InspireMD's official website. This digital platform ensures easy access for anyone interested in following the financial discourse. The user-friendly interface allows participants to engage with the event seamlessly, fostering a connection between the company and its investors.
About InspireMD
Founded on the mission of enhancing vascular intervention techniques, InspireMD utilizes its proprietary MicroNet™ mesh technology in developing its products. The ultimate goal is to set a new benchmark in carotid stenting, focusing on achieving outstanding acute results that translate into durable, long-term outcomes that significantly reduce the risk of stroke. These advancements represent InspireMD's commitment to not only enhance clinical practices but also ensure patient safety and satisfaction.
Investor Relations at InspireMD
In case investors have further inquiries or require additional assistance, InspireMD offers direct channels for communication. Webb Campbell of the Gilmartin Group LLC serves as the main contact for investor relations and is available to handle any queries. His insights and support are essential in guiding investors through their decisions with InspireMD's innovative solutions.
Frequently Asked Questions
What are the expected financial highlights for InspireMD's Q2 2025?
The financial highlights will showcase key revenue figures, potential market growth opportunities, and projected earnings, providing insight into the company's trajectory and financial health.
How can I attend the InspireMD earnings call?
Investors can dial in using the provided phone numbers for both domestic and international attendees or join via the webcast accessible from InspireMD's official website.
What makes InspireMD's CGuard Prime stent unique?
InspireMD's CGuard Prime is characterized by its MicroNet™ mesh technology, which enhances safety and efficacy in stroke prevention procedures compared to traditional solutions.
Who can I contact for more information about InspireMD?
Webb Campbell from the Gilmartin Group LLC is the investor relations contact for InspireMD and is available for inquiries.
Where can I find more updates from InspireMD?
Interested parties should visit InspireMD's official website, where they post updates and critical information for investors regularly.
